Market Cap : 45.34 M | Enterprise Value : 45.34 M | PE Ratio : At Loss | PB Ratio : |
---|
OTCPK:INSV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:INSV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2022-08-17), InSite Vision's 6-1 Month Momentum % is 133.33%.
The industry rank for InSite Vision's 6-1 Month Momentum % or its related term are showing as below:
INSV's 6-1 Month Momentum % is not rankedFor the Drug Manufacturers - Specialty & Generic subindustry, InSite Vision's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, InSite Vision's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where InSite Vision's 6-1 Month Momentum % falls into.
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum % | = | ( Price 1-month ago | / | Price 6-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of InSite Vision's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Drapeau Louis | officer: Vice President and CFO | C/O BIOMARIN PHARMACEUTICAL INC. 371 BEL MARIN KEYS BLVD., SUITE 210 NOVATO CA 94949 |
Levy Brian | director | |
Yost Anthony J | director | C/O INSITE VISION, INC. 965 ATLANTIC AVENUE ALAMEDA CA 94501 |
Mcinerney Timothy | director | |
Tooman Craig A | director | |
Coliseum Capital Management, Llc | 10 percent owner | 105 ROWAYTON AVENUE ROWAYTON CT 06853 |
Lynch Timothy P | director | 919 NW BOND STREET, SUITE 204 BEND OR 97703 |
Anderson Rick D | director | 3600 N CAPITAL OF TEXAS HWY SUITE B180 AUSTIN TX 78746 |
Saxe Jon S | director | FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076 |
Chen Francis Wen-hou | director | 1821 JONES STREET SAN FRANCISCO CA 94109 |
Pinto Tv Gp Co Llc | 10 percent owner | 3600 N CAPITAL OF TEXAS HWY SUITE B180 AUSTIN TX 78746 |
Crawford Matthew S | 10 percent owner | 3600 N CAPITAL OF TEXAS HWY SUITE B180 AUSTIN TX 78746 |
Pfizer Inc | 10 percent owner | 235 E 42ND ST NEW YORK NY 10017 |
No Headlines